ENTRY       hsa05321                    Pathway
NAME        Inflammatory bowel disease - Homo sapiens (human)
DESCRIPTION Inflammatory bowel disease (IBD), which includes Crohn disease (CD) and ulcerative colitis (UC), is characterized by chronic inflammation of the gastrointestinal tract due to environmental and genetic factors, infectious microbes, and the dysregulated immune system. Although many environmental factors (for example, geographic locations, smoking, etc.) affect the development of IBD, the most crucial might be the luminal (external) environment of the epithelial cells. There are pathogens that are found in increasing frequency in IBD. The microbial components such as flagellin, peptidoglycan, and lipopolysaccharide are recognized by receptors such as toll-like receptors (TLRs) and nucleotide-binding oligomerization domain (NOD) proteins, and also by antigen-presenting cells (APCs) in genetically susceptible host. The TLR recognition triggers the activation of NF-kappaB, leading to an inflammatory response. APC-expressed gene NOD2 has been associated with Crohn disease. In case of mutations of NOD2, negative regulation of IL-12 production is reduced with the stimulation of muramyl dipeptide (MDP), leading to CD. In addition, the APC mediates the differentiation of naive T cells into effector T cells (Th1, Th17, Th2) and natural killer T (NKT) cells. Th1 and Th17 cells produce high levels of IFN-gamma and IL-17, -22, respectively, both of which promote CD. In contrast, Th2 cells produce IL-4, -5, -10, which together with IL-13 from NKT induce UC.
CLASS       Human Diseases; Immune disease
PATHWAY_MAP hsa05321  Inflammatory bowel disease
DISEASE     H01227  Inflammatory bowel disease (IBD)
DRUG        D02597  Adalimumab (USAN/INN)
            D02598  Infliximab (USAN/INN)
            D04358  Golimumab (USAN/INN)
ORGANISM    Homo sapiens (human) [GN:hsa]
GENE        112744  IL17F; interleukin 17F [KO:K05494]
            149233  IL23R; interleukin 23 receptor [KO:K05065]
            2625  GATA3; GATA binding protein 3 [KO:K17895]
            30009  TBX21; T-box transcription factor 21 [KO:K10166]
            3108  HLA-DMA; major histocompatibility complex, class II, DM alpha [KO:K06752]
            3109  HLA-DMB; major histocompatibility complex, class II, DM beta [KO:K06752]
            3111  HLA-DOA; major histocompatibility complex, class II, DO alpha [KO:K06752]
            3112  HLA-DOB; major histocompatibility complex, class II, DO beta [KO:K06752]
            3113  HLA-DPA1; major histocompatibility complex, class II, DP alpha 1 [KO:K06752]
            3115  HLA-DPB1; major histocompatibility complex, class II, DP beta 1 [KO:K06752]
            3117  HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1 [KO:K06752]
            3118  HLA-DQA2; major histocompatibility complex, class II, DQ alpha 2 [KO:K06752]
            3119  HLA-DQB1; major histocompatibility complex, class II, DQ beta 1 [KO:K06752]
            3120  HLA-DQB2; major histocompatibility complex, class II, DQ beta 2 [KO:K06752]
            3122  HLA-DRA; major histocompatibility complex, class II, DR alpha [KO:K06752]
            3123  HLA-DRB1; major histocompatibility complex, class II, DR beta 1 [KO:K06752]
            3125  HLA-DRB3; major histocompatibility complex, class II, DR beta 3 [KO:K06752]
            3126  HLA-DRB4; major histocompatibility complex, class II, DR beta 4 [KO:K06752]
            3127  HLA-DRB5; major histocompatibility complex, class II, DR beta 5 [KO:K06752]
            3458  IFNG; interferon gamma [KO:K04687]
            3459  IFNGR1; interferon gamma receptor 1 [KO:K05132]
            3460  IFNGR2; interferon gamma receptor 2 [KO:K05133]
            3552  IL1A; interleukin 1 alpha [KO:K04383]
            3553  IL1B; interleukin 1 beta [KO:K04519]
            3558  IL2; interleukin 2 [KO:K05429]
            3561  IL2RG; interleukin 2 receptor subunit gamma [KO:K05070]
            3565  IL4; interleukin 4 [KO:K05430]
            3566  IL4R; interleukin 4 receptor [KO:K05071]
            3567  IL5; interleukin 5 [KO:K05428]
            3569  IL6; interleukin 6 [KO:K05405]
            3586  IL10; interleukin 10 [KO:K05443]
            3592  IL12A; interleukin 12A [KO:K05406]
            3593  IL12B; interleukin 12B [KO:K05425]
            3594  IL12RB1; interleukin 12 receptor subunit beta 1 [KO:K05063]
            3595  IL12RB2; interleukin 12 receptor subunit beta 2 [KO:K05064]
            3596  IL13; interleukin 13 [KO:K05435]
            3605  IL17A; interleukin 17A [KO:K05489]
            3606  IL18; interleukin 18 [KO:K05482]
            3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]
            4087  SMAD2; SMAD family member 2 [KO:K04500]
            4088  SMAD3; SMAD family member 3 [KO:K23605]
            4094  MAF; MAF bZIP transcription factor [KO:K09035]
            4772  NFATC1; nuclear factor of activated T cells 1 [KO:K04446]
            4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]
            50615  IL21R; interleukin 21 receptor [KO:K05075]
            50616  IL22; interleukin 22 [KO:K05445]
            50943  FOXP3; forkhead box P3 [KO:K10163]
            51561  IL23A; interleukin 23 subunit alpha [KO:K05426]
            59067  IL21; interleukin 21 [KO:K05434]
            5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]
            6095  RORA; RAR related orphan receptor A [KO:K08532]
            6097  RORC; RAR related orphan receptor C [KO:K08534]
            64127  NOD2; nucleotide binding oligomerization domain containing 2 [KO:K10165]
            6772  STAT1; signal transducer and activator of transcription 1 [KO:K11220]
            6774  STAT3; signal transducer and activator of transcription 3 [KO:K04692]
            6775  STAT4; signal transducer and activator of transcription 4 [KO:K11222]
            6778  STAT6; signal transducer and activator of transcription 6 [KO:K11225]
            7040  TGFB1; transforming growth factor beta 1 [KO:K13375]
            7042  TGFB2; transforming growth factor beta 2 [KO:K13376]
            7043  TGFB3; transforming growth factor beta 3 [KO:K13377]
            7097  TLR2; toll like receptor 2 [KO:K10159]
            7099  TLR4; toll like receptor 4 [KO:K10160]
            7100  TLR5; toll like receptor 5 [KO:K10168]
            7124  TNF; tumor necrosis factor [KO:K03156]
            8807  IL18RAP; interleukin 18 receptor accessory protein [KO:K05174]
            8809  IL18R1; interleukin 18 receptor 1 [KO:K05173]
REFERENCE   PMID:20134493
  AUTHORS   Melmed GY, Targan SR
  TITLE     Future biologic targets for IBD: potentials and pitfalls.
  JOURNAL   Nat Rev Gastroenterol Hepatol 7:110-7 (2010)
            DOI:10.1038/nrgastro.2009.218
REFERENCE   PMID:18200661
  AUTHORS   Shih DQ, Targan SR
  TITLE     Immunopathogenesis of inflammatory bowel disease.
  JOURNAL   World J Gastroenterol 14:390-400 (2008)
            DOI:10.3748/wjg.14.390
REFERENCE   PMID:17499605
  AUTHORS   Baumgart DC, Carding SR
  TITLE     Inflammatory bowel disease: cause and immunobiology.
  JOURNAL   Lancet 369:1627-40 (2007)
            DOI:10.1016/S0140-6736(07)60750-8
REFERENCE   PMID:16493424
  AUTHORS   Strober W, Murray PJ, Kitani A, Watanabe T
  TITLE     Signalling pathways and molecular interactions of NOD1 and NOD2.
  JOURNAL   Nat Rev Immunol 6:9-20 (2006)
            DOI:10.1038/nri1747
REFERENCE   PMID:21487504
  AUTHORS   Matricon J, Barnich N, Ardid D
  TITLE     Immunopathogenesis of inflammatory bowel disease.
  JOURNAL   Self Nonself 1:299-309 (2010)
            DOI:10.4161/self.1.4.13560
REFERENCE   PMID:12797537
  AUTHORS   Agnello D, Lankford CS, Bream J, Morinobu A, Gadina M, O'Shea JJ, Frucht DM
  TITLE     Cytokines and transcription factors that regulate T helper cell differentiation: new players and new insights.
  JOURNAL   J Clin Immunol 23:147-61 (2003)
            DOI:10.1023/A:1023381027062
REFERENCE   PMID:10898785
  AUTHORS   Glimcher LH, Murphy KM
  TITLE     Lineage commitment in the immune system: the T helper lymphocyte grows up.
  JOURNAL   Genes Dev 14:1693-711 (2000)
            DOI:10.1101/gad.14.14.1693
REFERENCE   PMID:12042806
  AUTHORS   Neurath MF, Finotto S, Glimcher LH
  TITLE     The role of Th1/Th2 polarization in mucosal immunity.
  JOURNAL   Nat Med 8:567-73 (2002)
            DOI:10.1038/nm0602-567
REFERENCE   PMID:12006974
  AUTHORS   Afkarian M, Sedy JR, Yang J, Jacobson NG, Cereb N, Yang SY, Murphy TL, Murphy KM
  TITLE     T-bet is a STAT1-induced regulator of IL-12R expression in naive CD4+ T cells.
  JOURNAL   Nat Immunol 3:549-57 (2002)
            DOI:10.1038/ni794
REFERENCE   PMID:18242222
  AUTHORS   Sartor RB
  TITLE     Microbial influences in inflammatory bowel diseases.
  JOURNAL   Gastroenterology 134:577-94 (2008)
            DOI:10.1053/j.gastro.2007.11.059
REFERENCE   PMID:9759857
  AUTHORS   Yoshimoto T, Takeda K, Tanaka T, Ohkusu K, Kashiwamura S, Okamura H, Akira S, Nakanishi K
  TITLE     IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production.
  JOURNAL   J Immunol 161:3400-7 (1998)
REFERENCE   PMID:23176791
  AUTHORS   Hur SJ, Kang SH, Jung HS, Kim SC, Jeon HS, Kim IH, Lee JD
  TITLE     Review of natural products actions on cytokines in inflammatory bowel disease.
  JOURNAL   Nutr Res 32:801-16 (2012)
            DOI:10.1016/j.nutres.2012.09.013
REFERENCE   PMID:18563156
  AUTHORS   Bettelli E, Korn T, Oukka M, Kuchroo VK
  TITLE     Induction and effector functions of T(H)17 cells.
  JOURNAL   Nature 453:1051-7 (2008)
            DOI:10.1038/nature07036
REFERENCE   PMID:18053739
  AUTHORS   Ivanov II, Zhou L, Littman DR
  TITLE     Transcriptional regulation of Th17 cell differentiation.
  JOURNAL   Semin Immunol 19:409-17 (2007)
            DOI:10.1016/j.smim.2007.10.011
REFERENCE   PMID:19322214
  AUTHORS   Di Cesare A, Di Meglio P, Nestle FO
  TITLE     The IL-23/Th17 axis in the immunopathogenesis of psoriasis.
  JOURNAL   J Invest Dermatol 129:1339-50 (2009)
            DOI:10.1038/jid.2009.59
REFERENCE   PMID:19381306
  AUTHORS   Jetten AM
  TITLE     Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism.
  JOURNAL   Nucl Recept Signal 7:e003 (2009)
            DOI:10.1621/nrs.07003
REFERENCE   PMID:21681604
  AUTHORS   Bene L, Falus A, Baffy N, Fulop AK
  TITLE     Cellular and molecular mechanisms in the two major forms of inflammatory bowel disease.
  JOURNAL   Pathol Oncol Res 17:463-72 (2011)
            DOI:10.1007/s12253-011-9397-4
REL_PATHWAY hsa04060  Cytokine-cytokine receptor interaction
            hsa04612  Antigen processing and presentation
            hsa04620  Toll-like receptor signaling pathway
            hsa04621  NOD-like receptor signaling pathway
            hsa04630  JAK-STAT signaling pathway
            hsa04659  Th17 cell differentiation
            hsa04660  T cell receptor signaling pathway
KO_PATHWAY  ko05321
///
